A group of 107 patients with lower urinary tract symptoms (LUTS) from benign prostatic enlargement (BPE) participated to the HOUSE Study (Home and Office Uroflowmetry Specific Evaluation). Patients received routine investigation, consisting of medical history taking, physical examination including digital rectal examination, prostate-specific antigen (PSA), assessment of symptoms listed both on the International Prostate Symptom Score and on ICS-male questionnaire. We examined the results of uroflowmetry evaluation in this population; data were analysed to observe if any circadian changes of parameters obtained with home uroflowmetry could be detected. We searched a correlation between Q max , Q ave and ICS-benign prostatic hyperplasia symptom score: a significantly inverse correlation was found only for Q max , confirming Q max as a reliable parameter to quantify subjective symptoms. When examining the multiple flow curves recorded in the same patient with home uroflowmetry, voided volume and flow time had usually higher values during night-time: the existence of circadian changes of uroflowmetry parameters in patients with LUTS from BPE was confirmed, and lower values of average and maximum flow rates during sleep hours were recorded in the same patient. In conclusion, when evaluating the natural history or treatment outcome of individual patients or group of patients in clinical trials for evaluation of BPE and LUTS, an assessment including multiple measurements may be useful and of value.
Introduction
Uroflowmetry is a useful urodynamic tool for the objective assessment of infravesical obstruction, and is helpful in the decision-making process and management of benign prostatic hyperplasia (BPH). 1 Single-test office uroflowmetry cannot be regarded as universally reliable for the determination of bladder outflow obstruction (BOO) due to BPH; many patients, in fact, are unable to relax and void as usual at the clinic. Some authors, besides, found variability between consecutive flow measurements and circadian changes in various voiding parameters, and particularly in maximum flow rate. 2, 3 Therefore, any decision based on a single-flow measurement is questionable, since a natural situation is recommended when using uroflowmetry to depict a patient's normal voiding pattern. Data from a homebased portable flowmeter may accomplish this objective. Home uroflowmetry has been well accepted, 4 and it gave different information from free uroflowmetry. It provided an estimation of BOO for 46% of the patients if the home mean Q max was 414 ml/s. 4 The calculation of mean parameter values, such as Q max , becomes possible, in order to reduce the effect of random fluctuation in test results.
We examined uroflowmetry parameters obtained by office uroflowmetry and home-based portable uroflowmetry. The aim was to examine the results of uroflowmetry assessment in this population, to examine possible correlations of some uroflow parameters with symptom scores, and not to focus on objective assessment of BOO.
Patients and methods
A total of 107 patients from seven centres with LUTS from benign prostatic enlargement (BPE) underwent both office and home uroflowmetry: Home and Office Uroflow Specific Evaluation (HOUSE Study). The mean age was 64 y (s.d.78.4); range 38-80 y. All procedures were approved by the Institutional Review Boards at the different medical centres where the HOUSE Study was performed.
After office uroflowmetry, postvoid residual urine volume was determined by means of ultrasound. For home uroflowmetry, the Da Capo portable, battery powered system was used ( Figure 1 ). Instructions for handling the portable uroflowmeter were provided to patients. The recorded data include date, start time (s), interval to maximum flow (s), maximum flow rate (ml/ s), average flow rate (ml/s) and voided volume (ml). All measurements are in accordance with the International Continence Society definitions.
Patients received routine investigation, consisting of medical history taking, physical examination including digital rectal examination, PSA, assessment of symptoms listed both on the International Prostate Symptom Score and on ICS-male questionnaire. 5 All patients were supplied with the patient uroflowmetry unit for home use during 24-72 h. The apparatus was then returned to the clinic and the recorded data were retrieved. An expert manually examined all flows to correct blindly possible artefacts of uroflow parameters obtained with both equipments.
Manual correction of Q max was carried out whenever the recorded peak lasted less than 2 s: in fact, common uroflowmetry artefacts may be described as a result of 'flow wagging', particularly in males, or 'damping' of the measurement system.
To overcome the problem of small volume urination episodes, we calculated a figure termed adjusted peak flow rate; 6 it was calculated based on the voiding nomograms as proposed by Siroky et al.
All correlations were evaluated using Pearson's r, measuring the relation between two variables, including the confidence interval of correlation coefficient. Statistically significant values are written in italics.
Results
Data from 95 out of 107 patients recruited for the study were available for analysis of office uroflowmetry. In 12 patients the data were incomplete due to insufficient voided volumes or multiple artefacts of home uroflow traces. A total of 1068 traces were available for analysis with home uroflowmetry in 89 patients, with an average of 12 uroflow traces per patient during 24 h-time (minmax: 5-45). Besides, the average number of voids was 9 during daytime (min-max: 4-36), 3 during night time (min-max: 2-15).
In Table 1 , values of uroflow parameters of office uroflowmetry and home uroflowmetry are reported and compared. Uroflow parameters of home uroflowmetry were evaluated both during daytime (0600-2400 hours) and during night-time (2400-0600 hours). Results of 'volume adjusted' peak flow rates are reported in Table  2a , b. As shown, only voided volumes above 100 ml were considered and analysed. Data of maximum and average flow were always calculated after revision of flow curves and elimination of artefacts, performed blindly by a single expert.
Maximum voided volume was not found to be correlated with advancing age or IPSS. It was, however, significantly lower in men with a reduced Q max (o15 ml/s) (Po0.009). When examining the multiple flow curves recorded in the same patient with home uroflowmetry, voided volume and flow time had usually higher values during night time. No significant differences were recorded between morning and afternoon uroflow curves and parameters (P ¼ 0.8). Average flow and Q max were evaluated in four different time intervals; 6-12, 12-18; 18-24, 18-24 h: they were usually higher during daytime: median values of Q max and Q ave were 13.4 and 7.2 during daytime between 6-24 h, 11.7 ml/s and 6.4 during night time between 24-6 h, respectively (Table 3 ) (Po0.01, Po0.05, respectively). Mean voided volumes were significantly higher between midnight and 0600 hours than during daytime (Po0.01) ( Table 3) .
Q max , Q ave , and voided volume were then examined in relation with the age of patients. Patients were divided into two classes of age: 460 and o60 y. Q max , as well as Q ave , were comparable in both classes of patients. Also total voided volume did not appear to be related with age.
A correlation was searched between Q max , Q ave and ICS-BPH symptom score (total score): a significantly inverse correlation was found only for Q max (P-value ¼ 0.0158).
Urinary frequency was significantly correlated with IPSS item QoL, ICS-BPH symptom score item bother, and domain frequency of ICS-BPH symptom score (P ¼ 0.001, 0.0005, 0.0001, respectively).
Discussion
One of the key questions in the treatment of patients with lower urinary tract symptoms and BPH is whether they have BOO. 7 A variety of objective and subjective parameters can be determined to quantify the degree of complaints, although pressure-flow analysis is still the gold standard to evaluate the grade of BOO, and no method can be used in its place for this purpose, not even multiple uroflow traces. A prerequisite for a measuring 8 On the other hand, in pharmacological trials for BPH, the effect-sizes in terms of increase in Q max and average flow rate are usually small. Therefore the question is, what should be the absolute magnitude of change be to conclude that the flow rate of an individual patient has improved? How many measurements are required? Some authors 8 found that many measurements are needed.
The variation in home-based Q max measurements has been quantified. 9 By using portable uroflowmetry, the Q max found on a single occasion may deviate approximately 50% from the true mean Q max of that patient. 9 Producing multiple flows reduces the random fluctuation in mean Q max . Calculating a mean Q max of, for instance, 12 flows (voided volume 4100 ml), results in a decrease of this deviation from 50 to 15%.
When analysing uroflow curves of a symptomatic BPH population, it should be considered that the estimation of Q max of all patients at a common voided volume disregards the fact that unobstructed patients are able to void larger volumes and thus obtain higher Q max than obstructed patients. Volume adjustments may therefore further decrease the diagnostic value of uroflowmetry. A second cause of variation in Q max consists of a circadian rhythm. Our study shows that flows are poorer during night time and early morning, their parameters improving during daytime. The difference between both extremes was o2 ml/s on average, and standardizing Q max values according to this rhythm had only minor implications for the variability in Q max . 9 There seems to be an intraindividual difference in voiding during the day compared to the night: 10, 11 when the 24 h is divided into active time and sleep time, the mean Q max of the active time is significantly greater than those of the sleep time. The finding of increased voided volumes during night time has already been observed. Golomb et al, 3 however, observed lower maximum and adjusted maximum flow rates between midnight and noon; we found a significant difference of average and maximum flow rates between midnight and 0600 hours, that is between sleep hours and the time of normal daily activities. Our study group is representative enough, being the largest so far to confirm the finding of changes in voiding patterns in relationship to the time of the day.
One could speculate on this observation, which might be the result of a prevalence of alpha-sympathetic tone during nigh time. Specific cardiovascular assessment, possibly combined with extramural urodynamic monitoring, could provide useful information on this issue.
Home-based flowmetry seems to provide additional information especially for patients in clinical trials for evaluation of symptomatic BPH and LUTS, and for the evaluation of new drugs and compare their effects during 24-h time. This equipment seems to mirror more accurately the voiding pattern of the patient and give more accurate readings. In a recent study 10 on a large group of aged men, urine production in men younger than 65 y showed a clear circadian pattern in contrast to men older than 65 y. Use of diuretics, postvoid residual and 24-h polyuria reinforced the circadian pattern in favour of daytime urine production, which was not associated with prostate enlargement, reduced Q max , hypertension, and cardiac symptoms.
BPH is characterized by a variability in the values of home uroflowmetry parameters over time. Our study shows that there is a close relationship between the Q max obtained with home and free uroflowmetry, while the voided volume and the voided time obtained in clinic free uroflowmetry are significantly higher than those measured at home. The hesitations a patient may have when requested to void in the Hospital is minimized with home uroflowmetry, thus eliminating a possible 'white-coat' influence on micturition.
Conflicting results have been reported in previous studies on the correlation of flow variables and symptoms. Maximum flow rate has been shown to be significantly associated with symptom scores in some studies, 12, 13 while other investigations have shown only weak correlations. 14, 15 We searched a correlation between Q max , Q ave and ICS-BPH symptom score: a significantly inverse correlation was found only for Q max , confirming Q max as a reliable parameter to quantify subjective symptoms.
Urinary frequency was significantly correlated with IPSS item QoL, ICS-BPH symptom score item bother, and domain frequency of ICS-BPH symptom score (P ¼ 0.001, 0.0005, 0.0001, respectively). It is possible, although little evidence exists, that voiding symptoms are more affected by the degree of outlet obstruction, while storage disorders may imply more complex pathophysiological mechanisms on which additional variables, such as different treatments, may have puzzling effects.
Storage and voiding symptoms were analysed separately in a recent study, 15 showing that the correlation was lower for storage than for voiding symptoms.
When the relation between bladder capacity and LUTS was explored in a large group of elderly men, 16 the average volume per void and functional bladder capacity (FBC), defined as the largest single voided volume on frequency-volume chart, declined with advancing age, and FBC was lower in men with a reduced Q max (o15 ml/s) and independent of the postvoid residual volume. This could be due to the fact that voided volume is related to Q max , which, in turn, revealed no inverse correlation with advancing age when the cutoff value was 60 y. FBC was strongly related to LUTS, and a low FBC coincided with higher IPSS. In our experience FBC, was not found to be correlated with advancing age or IPSS. It was, however, significantly lower in men with a reduced Q max (o15 ml/s) (Po0.009). This difference may be due to the different way of evaluation of FBC in our patients, which was home uroflowmetry instead of voiding diary.
Conclusions
Home uroflowmetry supplies the urologist with a large number of uroflow curves, including flows produced outside office hours. Multiple uroflowmetry recordings will probably have little bearing on the diagnostic process of a single patient by an experienced urologist. 
